Thank you, Madam Chair. I would like to ask some questions of Professor Evenett.
First, would you be able to talk about the importance of vaccine producers being able to work with manufacturers globally to ensure the vaccines being produced are up to standard and effective, specifically where there could potentially be risks that might arise with quality control if vaccines are produced under the TRIPS waiver?